| Finding | Percentage | Cases |
|---|---|---|
| Gender | ||
| Male | 100% | 20/20 |
| Female | 0% | 0/20 |
| Indifferent | 0% | 0/20 |
| Unknown | 0% | 0/20 |
| General | ||
| 15% | 3/20 | |
| 20% | 4/20 | |
| 25% | 5/20 | |
| 30% | 6/20 | |
| 60% | 12/20 | |
| 90% | 18/20 | |
| 55% | 11/20 | |
| 65% | 13/20 | |
| 89.5% | 17/19 | |
| 78.9% | 15/19 | |
| Neurology | ||
| 20% | 4/20 | |
| 70% | 14/20 | |
| 10% | 2/20 | |
| Facial abnormalities | ||
| 35% | 7/20 | |
| 35% | 7/20 | |
| 20% | 4/20 | |
| 20% | 4/20 | |
| Visual and hearing impairments | ||
| 5% | 1/20 | |
| 10% | 2/20 | |
| Heart | ||
| Abnormality of the heart | 0% | 0/20 |
| Pulmonary | ||
| Abnormality of the lungs | 0% | 0/18 |
| Gastrointestinal | ||
| 5% | 1/20 | |
| Urogenital | ||
| 35% | 7/20 | |
| Skeleton | ||
| 40% | 8/20 | |
| Skin / Hair / Nails | ||
| 15% | 3/20 | |
| Endocrine / Immunological / Metabolic | ||
| Endocrine | 0% | 0/20 |
| Metabolic | 0% | 0/20 |
| Immune | 0% | 0/20 |
| Neoplasia | ||
| 5% | 1/20 | |
| Inheritance | ||
| 50% | 10/20 | |
BRWD3